S. Hapuarachchige

发表

Design and synthesis of a new class of membrane-permeable triazaborolopyridinium fluorescent probes.

Delany Rodriguez, J. B. Arterburn, C. Ramesh, 2011, Journal of the American Chemical Society.

Click Therapy: Novel Concept in Pretargeting Drug Delivery

Sudath Hapuarachchige, S. Hapuarachchige, 2017 .

Bioorthogonal, two-component delivery systems based on antibody and drug-loaded nanocarriers for enhanced internalization of nanotherapeutics.

Yoshinori Kato, Dmitri Artemov, D. Artemov, 2014, Biomaterials.

Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy.

V. Raman, D. Artemov, C. Bařinka, 2020, Molecular pharmaceutics.

Development of 5D3 mAb and USPIO-Based Theranostics for Image-Guided Prostate Cancer Therapy

R. Morgan, D. Artemov, X. Xxxx, 2022 .

Cellular Delivery of Bioorthogonal Pretargeting Therapeutics in PSMA-Positive Prostate Cancer.

Martin G Pomper, S. Lupold, D. Artemov, 2019, Molecular pharmaceutics.

Bioorthogonal two-component drug delivery in HER2(+) breast cancer mouse models

D. Artemov, Y. Kato, Sudath Hapuarachchige, 2014, Scientific Reports.

Dual-Modality PET-SPECT Image-Guided Pretargeting Delivery in HER2(+) Breast Cancer Models.

Wojciech G. Lesniak, D. Artemov, R. Mease, 2021, Biomacromolecules.

Theranostic Pretargeting Drug Delivery and Imaging Platforms in Cancer Precision Medicine

D. Artemov, Sudath Hapuarachchige, S. Hapuarachchige, 2020, Frontiers in Oncology.

Click Chemistry in the Development of Contrast Agents for Magnetic Resonance Imaging

D. Artemov, Sudath Hapuarachchige, S. Hapuarachchige, 2016, Topics in magnetic resonance imaging : TMRI.

Theranostics and metabolotheranostics for precision medicine in oncology.

Z. Bhujwalla, Jiefu Jin, Marie-France Penet, 2018, Journal of magnetic resonance.

MR / OPTICAL IMAGE-GUIDED TWO-COMPONENT NANO-DELIVERY SYSTEMS TARGETING HER 2 / NEU OVEREXPRESSING CANCER CELLS

D. Artemov, Y. Kato, Wenlian Zhu, 2011 .